Study of the Safety, Tolerability, and Pharmacokinetics of REGN6490 in Healthy Japanese Adult Volunteers
Clinical trial NCT04616105 · TERMINATED
Trial details
- NCT number
- NCT04616105
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-18
- Primary completion
- 2021-05-28
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.